Promising patient trials surrounding this compound, specifically the 120 milligram formulation referred to as ZPHC, reveal a considerable impact on weight reduction and related health factors. Researchers posit that this combined compound, targeting both GLP-1 and GIP pathways , may offer a substantial improvement in the approach of excess weight